Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma
Authors:
- Byung Hyun ByunBBByung Hyun Byun
- Chang-Bae KongCKChang-Bae Kong
- Ilhan LimILIlhan Lim
- Byung Il KimBKByung Il Kim
- Chang Woon ChoiCCChang Woon Choi
- Won Seok SongWSWon Seok Song
- Wan Hyeong ChoWCWan Hyeong Cho
- Dae-Geun JeonDJDae-Geun Jeon
- Jae-Soo KohJKJae-Soo Koh
- Soo-Yong LeeSLSoo-Yong Lee
- Sang Moo LimSLSang Moo Lim
- 31 August 2013
- journal article
- research article
- Published by Springer Nature in Skeletal Radiology
- Vol. 42 (12) , 1673-1681
Abstract
We compared the diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and (99 m)Tc-methylene diphosphonate bone scintigraphy (BS) for the detection of bone metastasis in osteosarcoma. We retrospectively reviewed 206 patients with stage II–IV osteosarcoma treated with surgery and chemotherapy as well as at least one paired PET/CT and BS scan (defined as an examination). PET/CT and BS images were interpreted separately. When analyzing the diagnostic yield of a combination of PET/CT and BS (PET/CT+BS), an examination was considered positive if either PET/CT or BS scored positive. The final diagnosis was obtained from histological findings or clinical follow-up with imaging studies for at least 6 months. Diagnostic performances of PET/CT, BS, and their combinations were calculated. Out of 833 examinations in 206 patients, 55 with 101 lesions in 38 patients were confirmed as bone metastases. The sensitivity, specificity, and diagnostic accuracy were 95, 98, and 98 %, respectively, for PET/CT; 76, 97, and 96 %, respectively, for BS; and 100, 96, and 97 %, respectively, for PET/CT+BS in an examination-based analysis. Lesion-based analysis demonstrated that the sensitivity of PET/CT+BS (100 %) was significantly higher than that of PET/CT (92 %) or BS (74 %) alone. BS detected significantly less bone metastases in the growth plate region than outside the growth plate region (22 vs. 77 %). PET/CT is more sensitive and accurate than BS for diagnosing bone metastases in osteosarcoma. The combined use of PET/CT and BS improves sensitivity.Keywords
This publication has 23 references indexed in Scilit:
- Local Recurrence has only a Small Effect on Survival in High-risk Extremity OsteosarcomaClinical Orthopaedics and Related Research, 2012
- Design and performance evaluation of a whole-body Ingenuity TF PET–MRI systemPhysics in Medicine & Biology, 2011
- Comparison of 18F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patientsNuclear Medicine Communications, 2010
- Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRIJournal of Nuclear Medicine, 2009
- PET/CT for Therapy Response Assessment in LymphomaJournal of Nuclear Medicine, 2009
- Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor CommitteePediatric Blood & Cancer, 2008
- Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter TrialJournal of Clinical Oncology, 2007
- Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy The Rizzoli experience in 52 patientsActa Orthopaedica, 2006
- Comparison of18FDG-PET with99mTc-HMDP scntigraphy for the detection of bone metastases in patients with breast cancerAnnals of Nuclear Medicine, 2005
- Scintigraphic evaluation of the growth plateSeminars in Nuclear Medicine, 1993